Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 58 for “"GL261"”.
-
Anwendung eines GL261-Tumormodells in CCR2-defizienten Mäusen
… untersucht. Methoden: Die syngene Tumorzelllinie GL261 wurde stereotaktisch in das Gehirnparenchym von CCR2ko- und C57Bl6/J-Mäusen (Wildtyp) implantiert. Anhand von MRT-Messungen wurden die Tumorvolumina im Verlauf bestimmt (d7, d14, d21) und verglichen. Die Gehirne wurden durch histologische …
-
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
… isolate LIVP 1.1.1 replicate and lyse the murine GL261 glioma cell line in vitro. In the following, the replication efficacy was characterized in a comparative approach in vivo. Immunocompetent C57BL/6 (wt) mice and immunodeficient mouse strains of different genetic background C57BL/6 athymic and …
-
Zika Virus Oncolytic and Tumor Vaccine Adjuvant Immunotherapy Treatment of Murine Glioblastoma GL261
… vitro characterization of murine GBM cell line GL261 was carried out examining the presence of these putative receptors as well as their susceptibility to viral infection. The presence of Tyro3 and Axl RNA was confirmed by qRT-PCR and RNA-Seq although their role in ZIKV infection is still …
-
Expressão e funcionalidade do receptor P2X7 em linhagem de glioma de camundongo GL261
… estudadas, a linhagem de camundongo GL261 apresentou sensibilidade à morte induzida por ATP pela liberação de LDH, incorporação de iodeto de propídio e diminuição da viabilidade mitocondrial. O ATP foi tóxico em concentrações acima de 2 mM, o BzATP foi mais potente que o ATP e o …
-
Metronomic cylcophosphamide-activated anti-tumor immune responses: dose and schedule dependence in mouse models
… metronomic CPA schedules were investigated in GL261 gliomas implanted in scid mice. Metronomic CPA treatments spaced 9 or 12 days apart induced extensive tumor regression, however, tumor-infiltrating natural killer cell responses were not sustained, and tumor growth rapidly resumed after …
-
Immunological aspects of intratumoral chemotherapy and immunotherapy in malignant brain tumors
… models. CED of temozolomide (CED-TMZ) cured GL261-bearing mice and acted synergistically with wildtype cell immunizations. In addition, CED- TMZ was more effective and less toxic than single intratumoral injections of TMZ in the GL261 model. CED-TMZ prolonged survival in KR158-bearing mice …
-
Immunotherapy for murine glioma
… Red) was confirmed in the murine glioma line GL261 in vitro and in vivo. Orthotopic GL261 tumors in immunocompetent C57BL/6J mice were treated with vvDD-IL15Ra-YFP vaccinia virus or vMyx-IL15Ra-tdTr combined with other treatments, including vaccination with GARC-1 peptide (a neoantigen for …
-
Etablierung orthotoper Gehirntumor-Modelle in der Maus
… und ein xenogenes Medulloblastom-Modell: GL261-FLuc Glioblastom-Modell: Das Glioblastom ist ein seltener Tumor im Kindesalter. Die extrem schlechte Prognose macht neue Behandlungsstrategien jedoch dringend erforderlich. Immuntherapien könnten hier ein rationaler Ansatz sein. Durch …
-
Investigating the role of toll-like receptors in the glioma microenvironment
… for or deprived the mouse glioma cell line GL261 of GSCs by FACS. Over the same period of time, 100 CD133+ GSCs had the capacity to form a tumor of comparable size to the ones formed by 10000 CD133- GL261 cells. In IL-6-/- mice, only tumors formed by CD133+ cells were smaller when compared …
-
Oncolytic herpes simplex virus immuno-virotherapy in combination with TIGIT immune checkpoint blockade to treat glioblastoma
… of HSV-1 rQNestin34.5 was evaluated in CT-2A and GL261 syngeneic murine glioma models. Immunoassays were conducted to assess secretion of damage associated molecular patterns including ATP, HMGB1, Calreticulin, HSP70 and other proinflammatory mediators by infected glioma cells. In vitro screens …
-
Immunotherapy against malignant brain tumors - of mice and men
… based immunotherapy in the mouse glioma model, GL261. Mice with intracranial gliomas were immunized intraperitoneally with GL261 cell genetically modified to produce GM-CSF combined with recombinant IFNγ. This combination synergistically enhanced survival to 90%. In paper II-III we investigated …
-
The effect of cytosine deaminase-expressing mesenchymal stem cells in orthotopic glioma model of immune competent mice
… using a syngeneic mouse glioma cell line, GL261 in immune competent wild type C57BL/6 mice. GL261 cells (3x104 cells) were transplanted to the striatum and tumor growth kinetics was assessed by MRI imaging and histological analyses. The therapeutic effects of mesenchymal stem cells (MSC) …
-
Combined chemotherapy and immunotherapy against experimental malignant brain tumors
… tumor cells and recombinant IFNγ in the GL261 mouse glioma model is mediated by both CD4+ and CD8+ T cells, and evokes a long-term memory response that protects against secondary tumors without any further treatment. Further I report that TMZ and cisplatin, two chemotherapeutic agents, …
-
IMMUNOTHERAPY AGAINST THE RADIAL GLIA MARKER GLAST EFFECTIVELY TRIGGERS SPECIFIC ANTITUMOR EFFECTORS WITHOUT AUTOIMMUNITY
… trafficking, is highly expressed in murine GL261 glioma stem-like cells (GSC). In this study, we first investigated the functional consequences of GLAST enrichment using an immune-magnetic sorting approach to isolate GLAST+ cells from murine GSC. GLAST+ cells were significantly more …
-
The impact of CD13 on glioma progression
… Additionally, Cd13-overexpressing and knockout GL261 cells were generated and implanted into wild-type and Cd13-knockout mice (syngeneic mouse model) to analyze the impact of Cd13 expression on tumor progression. Tumor volumes were measured by magnetic resonance imaging. Results: Our analyses …
-
Strategies Involving the Food-Derived Agent Curcumin to Eliminate Brain Cancer
… into the brain of murine GBM cell line GL261-implanted mice to study the therapeutic effect of CC on GBM remission. The treatment caused GBM tumor remission in 50% of GL261-implanted GBM mice. A similar rescue rate (60%) was also achieved through long-term intraperitoneal (i.p) infusion …
-
The role of the gap junction protein connexin43 in glioma migration and invasion
… was observed when we reduced Cx43 in mouse GL261 glioma cells and deleted it in host astrocytes. Interestingly, blocking the channel in GL261 did not decrease invasion. In summary, a reduction in homocellular gap junction communication increases migration of glioma cells in vitro however …
-
Die Blockade des CXCR2/CXCL2 Signalweges als therapeutischer Ansatz im Glioblastoma multiforme
… den small-molecule Inhibitor SB225002. METHODEN GL261 Glioblastomzellen wurden intrakraniell in ein syngenes Mausmodell implantiert. Der Antagonist wurde mittels osmotischer Minipumpen direkt in den Ventrikel appliziert. Der 14- bzw. 7-tägige Behandlungszeitraum wurde am Tag der …
-
Combination metronomic chemotherapy and immunotherapy in preclinical mouse glioma models
… and increased tumor-infiltrating immune cells in GL261 gliomas implanted in immunocompetent mice. Although anti-tumor responses varied between individual animals, both high and low CpG-1826-responsive mice showed increased anti-tumor responses when CpG-1826 was combined with CPA treatment; …
-
Treatment of murine tumors with recombinant Myxoma viruses
… were fully-permissive to MYXV infection, while GL261 glioma cells were partially permissive, and EL4 cells were non-permissive. All stages of virus morphology were observed in the permissive cells and there was evidence of cell-to-cell spread of MYXV. Other studies have shown that the …
Page 1 of 3